Can you change the future? We think so.
Research is really about helping patients, families, friends - you. So, in celebration of our first ever research blog post, we will look at how you can impact research.
Research is really about helping patients, families, friends - you. So, in celebration of our first ever research blog post, we will look at how you can impact research.
Children’s Cancer and Leukaemia Group (CCLG) is proud to have become a partner of the National Cancer Research Institute (NCRI).
A pioneering research project funded by a Children’s Cancer and Leukaemia Group (CCLG) Special Named Fund is investigating how the wrong genes are being instructed in patients with T-cell leukaemia in the hope that the knowledge gleaned will inform treatments to stop cancer cells surviving.
Children’s Cancer and Leukaemia Group (CCLG) has published its first ever report showcasing the impact our research has had on driving forward pioneering breakthroughs into finding a cure for childhood cancer.
Experts from the University of Nottingham have developed a protocol for clinicians around the world which will help to close the gap between diagnosis and treatment of childhood cancer, and could increase the chance of survival from the disease.
In TYAC's ambitious strategy for 2020 - 2025, one of our aims was to lead and fund world-class research dedicated to teenage and young adult cancers. Following a hiatus due to the COVID-19 pandemic, today we're proud to launch our first research strategy to help fulfil that goal.
We are delighted to announce that CCLG partner The Little Princess Trust has been accepted into membership of the Association of Medical Research Charities (AMRC).
The Little Princess Trust has announced the recipients of its innovation research grants, awarded in partnership with CCLG.
A paper on childhood cancer awareness has been published in the British Journal of General Practice (BJGP).